Nexus and Nevakar face off over hypotension drug
19-08-2021
Federal Circuit invalidates cardiovascular diagnostics patents
19-06-2017
Novartis in $1bn cardiovascular deal with Ionis and Akcea
20-02-2017
Explode / Shutterstock.com
US cardiovascular therapies company Medicure has settled a patent infringement dispute with rival Nexus Pharmaceuticals.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Medicure, Nexus, Aggrasat, generics, licence, patent infringement, cardiovascular, ANDA, FDA, US District Court for the Northern District of Illinois
